Overall, the company from Vevey reported revenue of CHF 22.6 billion in the first three months of the new year, as announced ...

At the capital markets day at the end of March, Kühne + Nagel revised its strategy named «Roadmap 26.» Previously, the focus ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Roche slightly surpassed revenue expectations in the first three months. The company reaffirms its full-year guidance.

Fears are growing in the EU that sanctions against Russia may expire in July. Options for frozen foreign exchange reserves ...

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

The ongoing trade conflict and increasing economic concerns weigh heavily on earnings expectations. Yet, forecasts for the US ...

A Swiss financial centre initiative demands strict climate protection regulations for banks and insurers. UBS, Zurich ...

After Accelleron, ABB is preparing its next billion dollar Spin-off. The new CEO is making his mark and delivers good results ...

The CEO of the investment boutique Baker Steel sees investment opportunities in gold mines, lithium, and rare earths. He ...

The number of companies listed on the SIX Swiss Exchange is declining—due not only to structural changes but also partly due ...